These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
47. Coordinated changes of gut microbiome and lipidome differentiates nonalcoholic steatohepatitis (NASH) from isolated steatosis. Qian M; Hu H; Yao Y; Zhao D; Wang S; Pan C; Duan X; Gao Y; Liu J; Zhang Y; Yang S; Qi LW; Wang L Liver Int; 2020 Mar; 40(3):622-637. PubMed ID: 31782595 [TBL] [Abstract][Full Text] [Related]
48. A Cholecystokinin Receptor Antagonist Halts Nonalcoholic Steatohepatitis and Prevents Hepatocellular Carcinoma. Tucker RD; Ciofoaia V; Nadella S; Gay MD; Cao H; Huber M; Safronenka A; Shivapurkar N; Kallakury B; Kruger AJ; Kroemer AHK; Smith JP Dig Dis Sci; 2020 Jan; 65(1):189-203. PubMed ID: 31297627 [TBL] [Abstract][Full Text] [Related]
49. Temporal Development of Dyslipidemia and Nonalcoholic Fatty Liver Disease (NAFLD) in Syrian Hamsters Fed a High-Fat, High-Fructose, High-Cholesterol Diet. Svop Jensen V; Fledelius C; Max Wulff E; Lykkesfeldt J; Hvid H Nutrients; 2021 Feb; 13(2):. PubMed ID: 33673227 [TBL] [Abstract][Full Text] [Related]
50. Fucoxanthin inhibits hepatic oxidative stress, inflammation, and fibrosis in diet-induced nonalcoholic steatohepatitis model mice. Takatani N; Kono Y; Beppu F; Okamatsu-Ogura Y; Yamano Y; Miyashita K; Hosokawa M Biochem Biophys Res Commun; 2020 Jul; 528(2):305-310. PubMed ID: 32475638 [TBL] [Abstract][Full Text] [Related]
51. Tranilast, an antifibrogenic agent, ameliorates a dietary rat model of nonalcoholic steatohepatitis. Uno M; Kurita S; Misu H; Ando H; Ota T; Matsuzawa-Nagata N; Kita Y; Nabemoto S; Akahori H; Zen Y; Nakanuma Y; Kaneko S; Takamura T Hepatology; 2008 Jul; 48(1):109-18. PubMed ID: 18571789 [TBL] [Abstract][Full Text] [Related]
53. Progression of non-alcoholic steatosis to steatohepatitis and fibrosis parallels cumulative accumulation of danger signals that promote inflammation and liver tumors in a high fat-cholesterol-sugar diet model in mice. Ganz M; Bukong TN; Csak T; Saha B; Park JK; Ambade A; Kodys K; Szabo G J Transl Med; 2015 Jun; 13():193. PubMed ID: 26077675 [TBL] [Abstract][Full Text] [Related]
54. A mouse model for nonalcoholic steatohepatitis. Sundaresan S; Vijayagopal P; Mills N; Imrhan V; Prasad C J Nutr Biochem; 2011 Oct; 22(10):979-84. PubMed ID: 21190824 [TBL] [Abstract][Full Text] [Related]
55. [Mechanism study of the protective effects of selective cyclooxygenase-2 enzyme inhibitors on the liver of rats with type 2 diabetes mellitus combined with nonalcoholic steatohepatitis via Rho/ROCK pathway]. Yuan L; Tian F Zhonghua Gan Zang Bing Za Zhi; 2022 Jan; 30(1):74-80. PubMed ID: 35152673 [No Abstract] [Full Text] [Related]
56. ER stress-induced adipocytes secrete-aldo-keto reductase 1B7-containing exosomes that cause nonalcoholic steatohepatitis in mice. Gu H; Yang K; Shen Z; Jia K; Liu P; Pan M; Sun C Free Radic Biol Med; 2021 Feb; 163():220-233. PubMed ID: 33359683 [TBL] [Abstract][Full Text] [Related]
57. Ethyl pyruvate supplemented in drinking water ameliorates experimental nonalcoholic steatohepatitis. Sun X; Zhu S; Dong X; Strand-Amundsen RJ; Tonnessen TI; Yang R Biomed Pharmacother; 2021 May; 137():111392. PubMed ID: 33761609 [TBL] [Abstract][Full Text] [Related]
58. The indole derivative NecroX-7 improves nonalcoholic steatohepatitis in ob/ob mice through suppression of mitochondrial ROS/RNS and inflammation. Chung HK; Kim YK; Park JH; Ryu MJ; Chang JY; Hwang JH; Lee CH; Kim SH; Kim HJ; Kweon GR; Kim KS; Shong M Liver Int; 2015 Apr; 35(4):1341-53. PubMed ID: 25443620 [TBL] [Abstract][Full Text] [Related]
59. An improved mouse model that rapidly develops fibrosis in non-alcoholic steatohepatitis. Matsumoto M; Hada N; Sakamaki Y; Uno A; Shiga T; Tanaka C; Ito T; Katsume A; Sudoh M Int J Exp Pathol; 2013 Apr; 94(2):93-103. PubMed ID: 23305254 [TBL] [Abstract][Full Text] [Related]
60. Yellow loosestrife (Lysimachia vulgaris var. davurica) ameliorates liver fibrosis in db/db mice with methionine- and choline-deficient diet-induced nonalcoholic steatohepatitis. Son YJ; Jung DS; Shin JM; Kim M; Yoo G; Nho CW BMC Complement Med Ther; 2021 Jan; 21(1):44. PubMed ID: 33494735 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]